Fleury S.A. (BVMF:FLRY3)

Market Cap	9.41B +46.3%
Revenue (ttm)	8.29B +7.9%
Net Income	612.83M -0.5%
EPS	1.12 -0.5%
Shares Out	545.02M
PE Ratio	15.35
Forward PE	13.61
Dividend	1.21 (7.01%)
Ex-Dividend Date	Dec 3, 2025

Volume	133,700
Average Volume	3,015,165
Open	17.34
Previous Close	17.26
Day's Range	17.29 - 17.55
52-Week Range	11.95 - 18.10
Beta	0.35
RSI	68.33
Earnings Date	May 7, 2026

About Fleury

Fleury S.A., together with its subsidiaries, provides diagnostic imaging, clinical analysis, fertility, and infusions services in Brazil. It operates in two segments, Diagnostic Medicine and Integrated Medicine. The company also provides health management services, such as telemedicine; orthopedic medicine services; laboratory support; toxicological exam; preventive, integrated solutions, and clinical research in oncology; integrated solutions, research, development of processes and services in genomics; and laboratory analysis services. In add...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1926
• Employees: 28,000
• Stock Exchange: Brazil Stock Exchange
• Ticker Symbol: FLRY3

Financial Performance

In 2025, Fleury's revenue was 8.29 billion, an increase of 7.89% compared to the previous year's 7.68 billion. Earnings were 612.83 million, a decrease of -0.54%.